Ebb & Flow

If the data seem too good to be true, maybe they are. Last week, genomic testing company Sequenom Inc. (NASDAQ:

SQNM) disclosed that all the data that has been publicly released for its non-invasive SEQureDx Down syndrome test are "questionable."...